Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.

Cocco E, Benhamida J, Middha S, Zehir A, Mullaney K, Shia J, Yaeger R, Zhang L, Wong D, Villafania L, Nafa K, Scaltriti M, Drilon A, Saltz L, Schram AM, Stadler ZK, Hyman DM, Benayed R, Ladanyi M, Hechtman JF.

Cancer Res. 2019 Mar 15;79(6):1047-1053. doi: 10.1158/0008-5472.CAN-18-3126. Epub 2019 Jan 14.

PMID:
30643016
2.

A pair of datasets for microRNA expression profiling to examine the use of careful study design for assigning arrays to samples.

Qin LX, Huang HC, Villafania L, Cavatore M, Olvera N, Levine DA.

Sci Data. 2018 May 15;5:180084. doi: 10.1038/sdata.2018.84.

3.

Blocking and randomization to improve molecular biomarker discovery.

Qin LX, Zhou Q, Bogomolniy F, Villafania L, Olvera N, Cavatore M, Satagopan JM, Begg CB, Levine DA.

Clin Cancer Res. 2014 Jul 1;20(13):3371-8. doi: 10.1158/1078-0432.CCR-13-3155. Epub 2014 May 1.

4.

Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells.

Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelain M, Larson SM.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1933-8. Epub 2005 Jan 25.

Supplemental Content

Loading ...
Support Center